abstract |
The present invention relates to neurodegenerative disorders of dipeptidyl peptidase IV inhibitors (DPP-IV inhibitors) or pharmaceutically acceptable salts thereof, prevention of cognitive impairment, delay or treatment of progression and memory (short and long term). Both) and use to improve learning ability. |